15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Docebo Inc, 7 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $25.00 to $37.00, a moderate spread. The average target of $31.88 sits 52% above the current $21.02. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.47 next quarter toward $2.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy788%
Hold113%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to Docebo Inc.
As of Jul, 7 of 8 firms rate DCBO a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DCBO EPS & revenue forecast
EPS · NEXT QUARTER
$0.47
Range $0.39 – $0.57 · 7 analysts · +37% YoY
Next period, 7 analysts expect Docebo Inc to earn $0.47 a share (range $0.39 – $0.57), versus $0.34 a year earlier. Full-year consensus is $1.61, growing to $2.01 the year after.
REVENUE · NEXT QUARTER
$69.5M
Range $68.6M – $70.0M · 7 analysts · +13% YoY
Revenue is expected to reach $69.5M (range $68.6M – $70.0M), +12.9% year-over-year. Full-year consensus is $274.4M, rising to $300.8M next year.
Top analysts covering Docebo Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DCBO.
#1
George Sutton
Craig-Hallum · Rank #114
Buy
$62.00+195.0% to target
Overall win rate
36%
+ Follow
#2
Ryan MacDonald
Needham · Rank #386
Buy
$31.00+47.5% to target
Overall win rate
17%
+ Follow
#3
KK
Kevin Krishnaratne
Scotiabank
Buy
$25.00+18.9% to target
Coverage
—
+ Follow
#4
Josh Baer
Morgan Stanley
Hold
$26.00+23.7% to target
Coverage
—
+ Follow
#5
Matthew Vanvliet
Cantor Fitzgerald
Buy
$28.00+33.2% to target
Coverage
—
+ Follow
DCBO stock forecast FAQ
What is DCBO's average 12-month price target?+
The 8 analysts with a live target average $31.88 for Docebo Inc over the next 12 months, ranging from a $37.00 high to a $25.00 low.
Is DCBO stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 7 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DCBO?+
The Street-high target is $37.00 (TD Cowen), and the Street-low is $25.00 (Scotiabank). The average of all 8 active targets is $31.88.
How many Wall Street analysts cover DCBO?+
8 analysts have an active rating on Docebo Inc, and 8 firms carry a live 12-month price target.
Who is the most accurate analyst covering DCBO?+
Among analysts who currently cover DCBO, George Sutton of Craig-Hallum has the strongest overall Quantellect track record (Rank #114). Their current call is Buy with a $62.00 target.
What is Docebo Inc's projected EPS for next quarter?+
The consensus estimate is $0.47 per share (range $0.39 – $0.57) across 7 analysts. Full-year EPS is projected at $1.61, rising to $2.01 the following year.
How much revenue is Docebo Inc expected to report next quarter?+
Consensus revenue is $69.5M (range $68.6M – $70.0M). Full-year revenue is projected at $274.4M, growing to $300.8M next year.
Have analysts been upgrading or downgrading DCBO lately?+
As of Jul, 7 of 8 firms rate DCBO a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DCBO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
